Security key
40637HAF6
- Security type / class
- Debt / NOTE 1.000% 8/1
- Total 13F principal
- $680,559,400
- Total 13F market value
- $810,707,471
- SEC-reported market price (% of par)
- 118.98%
- Principal change
- +$86,839,000
- Number of holders
- 75
- Value change
- +$105,250,543
- Number of buys
- 31
- Number of sells
- 30
Report period
Q3 2024
Institutions
75
Top holders
10
40637HAF6 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Broader feeds
Reporting periods
Holder history for CUSIP 40637HAF6
Recent filing periods:
Ownership snapshot
Top reported holders of 40637HAF6 - HALOZYME THERAPEUTICS INC - NOTE 1.000% 8/1 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
—
Disclosed value leader
—
Comparable rows
0/0
Latest evidence
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
75
Principal
$680,559,400
Rows available
75
| Investor | Option | Weight % | Change % | SEC-reported value | * Price (% of par) | Principal | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
72
Q3 2024 holders
75
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend